Enterade: Clinical Trials

5 trials of Enterade, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 3, Terminated 2

Follow Enterade: new trials by email Literature Review of Enterade trials Research Report on Enterade

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Acceptability and Efficacy of Enterade (VS001) in Children at Risk for Environmental Enteric Dysfunction in Bangladesh
Enterade, Placebo - Environmental Enteric Dysfunction
Not applicableCompletedVirginia Commonwealth University202022-07-182022-09-10
Safety, Acceptability, and Feasibility of Enterade®
Enterade, Placebo - Stunting, Environmental Enteric Dysfunction
Not applicableTerminatedPATH122019-02-262021-02-04
Effects of an Amino Acid Mixture on Gastrointestinal Function, Inflammation and Fluid Balance: A Pilot Study in Patients With Inflammatory Bowel Disease
amino acid mixture beverage, glucose-based sports drink - Inflammatory Bowel Diseases, Short Bowel Syndrome
Not applicableTerminatedEntrinsic Bioscience Inc.72018-04-122023-03-23
"Beverage Hydration Index" of Commercial Therapeutic Beverages
enterade, Pedialyte, Gatorade - Healthy
Not applicableCompletedSonoma State University462017-02-172018-03-07
A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma
Enterade, Placebo, Standard Supportive Care - Multiple Myeloma, Non-Hodgkin's Lymphoma
Not applicableCompletedDana-Farber Cancer Institute1142016-10-012023-03-16

Conditions studied

Dehydration (1)  ·  Growth Disorders (1)  ·  Inflammatory Bowel Diseases (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)  ·  Short Bowel Syndrome (1)

Sponsors

Dana-Farber Cancer Institute (1)  ·  Entrinsic Bioscience Inc. (1)  ·  PATH (1)  ·  Sonoma State University (1)  ·  Virginia Commonwealth University (1)

Countries

United States (3)  ·  Bangladesh (1)  ·  Kenya (1)

Top investigators

Jeffrey R Donowitz, MD (1)  ·  Kurt J Sollanek, Ph.D. (1)  ·  Mahasweta Gooptu, MD (1)

Results publications

PMID 29635499